[go: up one dir, main page]

IS5590A - Bensoxasínón/bensóþíasínón notuð sem serínprótínkljúfatálmar - Google Patents

Bensoxasínón/bensóþíasínón notuð sem serínprótínkljúfatálmar

Info

Publication number
IS5590A
IS5590A IS5590A IS5590A IS5590A IS 5590 A IS5590 A IS 5590A IS 5590 A IS5590 A IS 5590A IS 5590 A IS5590 A IS 5590A IS 5590 A IS5590 A IS 5590A
Authority
IS
Iceland
Prior art keywords
benzothiazinone
benzoxazinone
protease inhibitors
serine protease
serine
Prior art date
Application number
IS5590A
Other languages
English (en)
Inventor
Alan Berryman Kent
Michael Downing Dennis
Andrea Dudley Danette
John Edmunds Jeremy
Sourirajan Narasimhan Lakshmi
Taras Rapundalo Stephen
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of IS5590A publication Critical patent/IS5590A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
IS5590A 1998-03-31 2000-08-18 Bensoxasínón/bensóþíasínón notuð sem serínprótínkljúfatálmar IS5590A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8014298P 1998-03-31 1998-03-31
PCT/US1998/026708 WO1999050257A1 (en) 1998-03-31 1998-12-15 Benzoxazinones/benzothiazinones as serine protease inhibitors

Publications (1)

Publication Number Publication Date
IS5590A true IS5590A (is) 2000-08-18

Family

ID=22155527

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5590A IS5590A (is) 1998-03-31 2000-08-18 Bensoxasínón/bensóþíasínón notuð sem serínprótínkljúfatálmar

Country Status (15)

Country Link
US (2) US6509335B1 (is)
EP (1) EP1068191A1 (is)
JP (1) JP2002509925A (is)
KR (1) KR20010042296A (is)
AU (1) AU765223C (is)
BR (1) BR9815784A (is)
CA (1) CA2319551A1 (is)
HU (1) HUP0101699A3 (is)
IL (1) IL137656A0 (is)
IS (1) IS5590A (is)
NO (1) NO20004698D0 (is)
NZ (1) NZ506985A (is)
PL (1) PL343317A1 (is)
WO (1) WO1999050257A1 (is)
ZA (1) ZA992445B (is)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291514B1 (en) 1998-02-09 2001-09-18 3-Dimensional Pharmaceuticals, Inc. Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
IL144560A0 (en) * 1999-02-09 2002-05-23 Dimensional Pharm Inc Heteroaryl amidine and guanidine derivatives and pharmaceutical compositions containing the same
FR2801885B1 (fr) * 1999-12-06 2002-01-11 Adir Nouveaux derives (dihydro)benzoxaziniques et (dihydro) benzothiaziniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20020013314A1 (en) * 2000-02-01 2002-01-31 Bing-Yan Zhu 3,4-dihydro-2H-benzo[1,4]oxazine inhibitors of factor Xa
AU2001234690A1 (en) 2000-02-01 2001-08-14 Cor Therapeutics, Inc. 2-(1h)-quinolone and 2-(1h)-quinoxalone inhibitors of factor xa
US7405158B2 (en) 2000-06-28 2008-07-29 Applied Materials, Inc. Methods for depositing tungsten layers employing atomic layer deposition techniques
US6998408B2 (en) 2001-03-23 2006-02-14 Bristol-Myers Squibb Pharma Company 6-5, 6-6, or 6-7 Heterobicycles as factor Xa inhibitors
WO2002080853A2 (en) 2001-04-09 2002-10-17 Bristol-Myers Squibb Company Fused heterocyclic inhibitors of factor xa
US6750215B2 (en) 2001-08-08 2004-06-15 Pharmacia & Upjohn, S.P.A. Substituted benzoxazines as integrin antagonists
US6794385B2 (en) 2001-08-08 2004-09-21 Pharmacia & Upjohn, S.P.A. Benzoxazine derivatives useful as integrin receptor antagonists
US6916398B2 (en) 2001-10-26 2005-07-12 Applied Materials, Inc. Gas delivery apparatus and method for atomic layer deposition
WO2003057672A2 (en) * 2001-12-28 2003-07-17 Acadia Pharmaceuticals, Inc. Tetrahydroquinoline analogues as muscarinic agonists
US6759298B2 (en) * 2002-06-24 2004-07-06 Micron Technology, Inc. Methods of forming an array of flash field effect transistors and circuitry peripheral to such array
HUE025683T2 (hu) 2002-12-03 2016-04-28 Pharmacyclics Llc VIIA faktor inhibitor 2-(2-hidroxi-bifenil-3-il)-1H-benzoimidazol-5-karboxamidin-származékok
TWI289141B (en) 2003-03-11 2007-11-01 Hoffmann La Roche F. Ag. Quinolinone derivatives and uses thereof
CN1859904A (zh) * 2003-10-03 2006-11-08 默克公司 用于治疗阿尔茨海默氏病的苄醚和苄氨基β－分泌酶抑制剂
SI21658A (sl) * 2003-11-28 2005-06-30 Univerza V Ljubljani Antitrombotične učinkovine z dualnim mehanizmom delovanja na osnovi 3,4-dihidro-2H-1,4-benzoksazinskega skeleta
AP2007003973A0 (en) * 2004-10-12 2007-07-30 Glenmark Pharmaceuticals Sa Novel dideptidyl peptidase IV inhibitors, pharmaceutical compositions containing them, and proces for their preparation
US20080269204A1 (en) * 2004-11-01 2008-10-30 Tatyana Dyakonov Compounds and Methods of Use Thereof
GB0515323D0 (en) 2005-07-26 2005-08-31 Electrophoretics Ltd Mass labels
US20070197512A1 (en) * 2006-01-27 2007-08-23 Japan Tobacco Inc. Carboxylic Acid Compounds and Use Thereof
WO2011024987A1 (ja) * 2009-08-31 2011-03-03 塩野義製薬株式会社 芳香族縮合へテロ環誘導体およびそれらを含有する医薬組成物
AU2012249240A1 (en) * 2011-04-29 2013-11-07 Icahn School Of Medicine At Mount Sinai Kinase inhibitors
JP6497808B2 (ja) * 2015-06-12 2019-04-10 アグロカネショウ株式会社 １，４−ベンゾチアジン−１，３−ジオン又は−１，１，３−トリオン誘導体およびこれを有効成分とする殺菌剤
IL291398B2 (en) 2019-10-01 2025-05-01 Molecular Skin Therapeutics Inc Benzoxazinone compounds as dual inhibitors of KLK5/7

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3006916A (en) * 1961-10-31 W-dialkylaminoalkyl
US3124577A (en) * 1964-03-10 Hydroxyalkyl cyclic amlno
US3089872A (en) * 1961-03-31 1963-05-14 Olin Mathieson Benzothiazine and benzothiazepine compounds
US3401166A (en) 1966-08-01 1968-09-10 Squibb & Sons Inc Therapeutically active benzothiazines
GB1174626A (en) * 1967-05-23 1969-12-17 Bellon Labor Sa Roger New Benzoxazine Derivatives
DE2044530A1 (de) 1970-02-04 1971-08-19 VEB Deutsches Hydrierwerk Rodleben, χ 4530 Roßlau Verfahren zur Herstellung basisch substituierter 2,3 Dihydro 1,4 benzoxazm 3 one
US3725403A (en) * 1970-10-20 1973-04-03 Squibb & Sons Inc Benzothiazine derivatives
FR2332756A1 (fr) 1975-11-26 1977-06-24 Squibb & Sons Inc Nouvelles 1, 4-benzoxazin-3(4h)-ones
US4584300A (en) * 1983-02-07 1986-04-22 Santen Pharmaceutical Co., Ltd. Platelet anti-aggregative- and calcium antagonistic -1,4-benzothiazin-3-one derivatives, compositions, and methods of use therefor
JPS60166674A (ja) 1984-02-09 1985-08-29 Santen Pharmaceut Co Ltd ベンゾチアジン誘導体
ATE71622T1 (de) * 1985-07-29 1992-02-15 Santen Pharmaceutical Co Ltd Neue benzothiazinabkoemmlinge.
JPH01272524A (ja) 1988-04-21 1989-10-31 Japan Found Cancer Res 癌化学療法剤
JP2886570B2 (ja) 1989-09-29 1999-04-26 エーザイ株式会社 縮合ヘテロ環を有する化合物
US5652237A (en) 1994-09-09 1997-07-29 Warner-Lambert Company 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes
JP3118380B2 (ja) 1994-09-30 2000-12-18 三洋電機株式会社 光学レンズの焦点調節装置
JPH09227561A (ja) 1996-02-21 1997-09-02 Tanabe Seiyaku Co Ltd キサンチン誘導体
WO1998021186A1 (en) * 1996-11-13 1998-05-22 Cephalon, Inc. Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors
EP0980362B1 (de) 1997-05-02 2006-08-16 Schering Aktiengesellschaft Substituierte heterocyclen und deren verwendung in arzneimitteln

Also Published As

Publication number Publication date
EP1068191A1 (en) 2001-01-17
IL137656A0 (en) 2001-10-31
ZA992445B (en) 1999-10-01
BR9815784A (pt) 2000-11-21
KR20010042296A (ko) 2001-05-25
CA2319551A1 (en) 1999-10-07
AU1918399A (en) 1999-10-18
HUP0101699A2 (hu) 2002-04-29
NZ506985A (en) 2003-10-31
AU765223B2 (en) 2003-09-11
WO1999050257A1 (en) 1999-10-07
AU765223C (en) 2004-03-18
PL343317A1 (en) 2001-08-13
HUP0101699A3 (en) 2002-05-28
US6509335B1 (en) 2003-01-21
NO20004698L (no) 2000-09-20
NO20004698D0 (no) 2000-09-20
US20030187256A1 (en) 2003-10-02
JP2002509925A (ja) 2002-04-02

Similar Documents

Publication Publication Date Title
IS5590A (is) Bensoxasínón/bensóþíasínón notuð sem serínprótínkljúfatálmar
NO20004697D0 (no) Benzoksazinoner/benzotiazinoner som serin protease inhibitorer
NO20011966L (no) Serin-protease-inhibitor
NO20004696D0 (no) Kinoloner som serinproteaseinhibitorer
ATE264339T1 (de) Serine protease inhibitoren
DE69819349D1 (de) 1-amino-7-isochinolin-derivate als serin protease inhibitoren
NO992734L (no) Serin-protease inhibitorer
NO20012980D0 (no) Proteaseinhibitorer
NO983688D0 (no) Serin-protease-inhibitorer
IL155202A0 (en) Biaryl compounds as serine protease inhibitors
EP1089752A4 (en) ALPHA-KETO OXADIAZOLE AS A SERINE PROTEASE INHIBITOR
DE60138717D1 (de) Peptidomimetika als protease inhibitoren
DE69730871D1 (de) Serine-protease-inhibitoren
DK0886647T3 (da) Serinproteasehæmmere
EP1179052A4 (en) SERINE PROTEASES
NO20011388D0 (no) Hydroksamat-inneholdende cystein- og serinproteasehemmere
AU6407701A (en) Serine protease inhibitors
EP1195163A4 (en) Serine protease inhibitors
EP1132477A4 (en) SERINE PROTEASE BSSP4
EP1206233A4 (en) Serine proteases
HK1038559A (en) Serine protease inhibitor
AU2002224552A1 (en) Serine protease